Memorial Sloan Kettering Cancer Center: New Study Reveals a Fiber Diet May Delay a Type of Blood Cancer
December 09, 2024
December 09, 2024
NEW YORK, Dec. 9 (TNSres) -- The Memorial Sloan Kettering Cancer Center issued the following news release on Dec. 7, 2024:
Today researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from the first ever clinical trial to show that a high fiber plant based dietary intervention may delay progression to multiple myeloma, a type of rare, incurable blood cancer affecting the bone marrow. The study enrolled 20 participants with a precancerous blood disorder and an e . . .
Today researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from the first ever clinical trial to show that a high fiber plant based dietary intervention may delay progression to multiple myeloma, a type of rare, incurable blood cancer affecting the bone marrow. The study enrolled 20 participants with a precancerous blood disorder and an e . . .